The analysts forecast global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020. To calculate the market size, we used the revenue generated from the sales of various types of regenerative medicine products.
The following companies are the key players in the global regenerative medicine market: Acelity, Medtronic, MiMedx Group, Organogenesis, UniQure, and ZimmerBiomet. Other Prominent Vendors in the market are: ACE Surgical Supply, Acologix, Advanced Biologics, AlloCure, Allosource, Alphatec Spine, Altrika, Amorcyte, Anterogen, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia, Biogen Idec, BioRestorative Therapies, Biostage, BioTissue Technologies, Bluebird Bio, BONESUPPORT, BrainStorm Cell Therapies, Caladrius Biosciences, Calimmune, Capricor Therapeutics, Celgene, Cell Medica, CellSeed, Cell Therapy, Celyad, CESCA THERAPEUTICS, CRC for Cell Therapy Manuracturing, Cryolife, Cynata Therapeutics, Cytori Therapeutics, Dendreon, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, FUJIFILM, Gamida Cell, Geron, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, ImmunoCellular Therapeutics, Integra LifeSciences, Intercytex, InVivo Therapeutics, iSTO Technologies, Janssen Pharma, Juno Therapeutics, Juventas Therapeutics, Kensey Nash, Kiadis Pharma, Kinetic Concept, LifeCell, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Mesoblast, Nanofiber Solutions CTO, Nanotope, NeoStem, Neuralstem, Newlink Genetics, Northwest Biotherapeutics, NovaRx, Ocata, Opexa Therapeutics, Organovo Holdings, Orteg, Orthofix, Osiris Therapeutics, Osteotech, Pfizer, Pharmicell, Pluristem Therapeutics, PrimaBioMed, Q Therapeutics, Regenerex, Regenerys, Regience, Regrow, RepliCel, ReproCELL, Renova Therapeutics, RhinoCyte, Rohto Pharmaceutical, RTI Surgical, SanBio, Sangamo BioSciences, Shanghai Sunway Biotech, Shire Regenerative Medicine, StemCells, Stratatech, Takara Bio, TEI Biosciences, tella, Tengion, Tissue Genesis, TissueGene, Txcell, VentriNova, Vericel, ViaCyte, and Vistagen.
Inquire for Discount at @ http://www.rnrmarketresearch.com/contacts/discount?rname=582848
According to the regenerative medicine market report a key growth driver for this market is the increased focus on cell therapy products. There are more than 40 approved cell therapy products in the market. Most small and large biotech companies are working on various cell types such as progenitor cells, adult and embryonic stem cells, and iPSCs. These cells have proved their efficacy in the treatment of chronic heart failure, cancer, and diabetes. Most of the cell therapy products are marketed for wound and dermal graft; however, there are only few products for cancer.
The global regenerative medicine market analyst said one trend that will positively impact the market is the high number of regenerative medicines in the pipeline. The global regenerative medicine market may witness the development and launch of many new therapies during the forecast period. There are many regenerative medicine pipeline products that are in different stages of development, ranging from discovery, pre-clinical phase to mid-stage and late-stage phase. As per the estimation in 2015, more than 2,500 regenerative medicine were under clinical trials
Order a copy of Global Regenerative Medicine Market 2016-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=582848
Global Regenerative Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.
Further, the report states that one challenge that could hamper market growth is the high cost and failure rate in clinical trials.
RnR Market Research
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
P: + 1 888 391 5441